The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Inhalable Drug Delivery Devices Market Research Report 2025

Global Inhalable Drug Delivery Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1677793

No of Pages : 101

Ask Your Query

Synopsis

Global Inhalable Drug Delivery Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inhalable Drug Delivery Devices market research.

Key manufacturers engaged in the Inhalable Drug Delivery Devices industry include Acorda Therapeutics Inc, Baxter International Inc, Bellerophon Therapeutics Inc, Zambon, Canigma A.L LTD, Edixomed Ltd, IDTx Systems, Inc., Impel NeuroPharma Inc and Kanabo Research Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Inhalable Drug Delivery Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Inhalable Drug Delivery Devices market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inhalable Drug Delivery Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Acorda Therapeutics Inc
  •     Baxter International Inc
  •     Bellerophon Therapeutics Inc
  •     Zambon
  •     Canigma A.L LTD
  •     Edixomed Ltd
  •     IDTx Systems, Inc.
  •     Impel NeuroPharma Inc
  •     Kanabo Research Ltd
  •     Mallinckrodt Plc
  •     Medical Developments International Ltd
  •     Medspray BV
  •     NeuroproteXeon Inc
  •     Next Safety, Inc.
  •     Nobilis Therapeutics Inc
  •     Sandoz International GmbH
  •     Vero biotech

Segment by Type

  •     Pressurized Metered Dose Inhalers (PMDIs)
  •     Nebulizers
  •     Dry Powder Inhalers (DPIs)
  •     Others

Segment by Application

  •     Hospital
  •     Clinic
  •     Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

 

The Inhalable Drug Delivery Devices report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

  1.1 Product Overview and Scope of Inhalable Drug Delivery Devices
    1.2 Inhalable Drug Delivery Devices Segment by Type
        1.2.1 Global Inhalable Drug Delivery Devices Market Value Comparison by Type (2023-2029)
        1.2.2 Pressurized Metered Dose Inhalers (PMDIs)
        1.2.3 Nebulizers
        1.2.4 Dry Powder Inhalers (DPIs)
        1.2.5 Others
    1.3 Inhalable Drug Delivery Devices Segment by Application
        1.3.1 Global Inhalable Drug Delivery Devices Market Value by Application: (2023-2029)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Inhalable Drug Delivery Devices Market Size Estimates and Forecasts
        1.4.1 Global Inhalable Drug Delivery Devices Revenue 2018-2029
        1.4.2 Global Inhalable Drug Delivery Devices Sales 2018-2029
        1.4.3 Global Inhalable Drug Delivery Devices Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Inhalable Drug Delivery Devices Market Competition by Manufacturers
    2.1 Global Inhalable Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Inhalable Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Inhalable Drug Delivery Devices Average Price by Manufacturers (2018-2023)
    2.4 Global Inhalable Drug Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Inhalable Drug Delivery Devices, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Inhalable Drug Delivery Devices, Product Type & Application
    2.7 Inhalable Drug Delivery Devices Market Competitive Situation and Trends
        2.7.1 Inhalable Drug Delivery Devices Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Inhalable Drug Delivery Devices Players Market Share by Revenue
        2.7.3 Global Inhalable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Inhalable Drug Delivery Devices Retrospective Market Scenario by Region
    3.1 Global Inhalable Drug Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Inhalable Drug Delivery Devices Global Inhalable Drug Delivery Devices Sales by Region: 2018-2029
        3.2.1 Global Inhalable Drug Delivery Devices Sales by Region: 2018-2023
        3.2.2 Global Inhalable Drug Delivery Devices Sales by Region: 2024-2029
    3.3 Global Inhalable Drug Delivery Devices Global Inhalable Drug Delivery Devices Revenue by Region: 2018-2029
        3.3.1 Global Inhalable Drug Delivery Devices Revenue by Region: 2018-2023
        3.3.2 Global Inhalable Drug Delivery Devices Revenue by Region: 2024-2029
    3.4 North America Inhalable Drug Delivery Devices Market Facts & Figures by Country
        3.4.1 North America Inhalable Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Inhalable Drug Delivery Devices Sales by Country (2018-2029)
        3.4.3 North America Inhalable Drug Delivery Devices Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Inhalable Drug Delivery Devices Market Facts & Figures by Country
        3.5.1 Europe Inhalable Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Inhalable Drug Delivery Devices Sales by Country (2018-2029)
        3.5.3 Europe Inhalable Drug Delivery Devices Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Inhalable Drug Delivery Devices Market Facts & Figures by Country
        3.6.1 Asia Pacific Inhalable Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2018-2029)
        3.6.3 Asia Pacific Inhalable Drug Delivery Devices Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Inhalable Drug Delivery Devices Market Facts & Figures by Country
        3.7.1 Latin America Inhalable Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Inhalable Drug Delivery Devices Sales by Country (2018-2029)
        3.7.3 Latin America Inhalable Drug Delivery Devices Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Inhalable Drug Delivery Devices Market Facts & Figures by Country
        3.8.1 Middle East and Africa Inhalable Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Inhalable Drug Delivery Devices Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Inhalable Drug Delivery Devices Sales by Type (2018-2029)
        4.1.1 Global Inhalable Drug Delivery Devices Sales by Type (2018-2023)
        4.1.2 Global Inhalable Drug Delivery Devices Sales by Type (2024-2029)
        4.1.3 Global Inhalable Drug Delivery Devices Sales Market Share by Type (2018-2029)
    4.2 Global Inhalable Drug Delivery Devices Revenue by Type (2018-2029)
        4.2.1 Global Inhalable Drug Delivery Devices Revenue by Type (2018-2023)
        4.2.2 Global Inhalable Drug Delivery Devices Revenue by Type (2024-2029)
        4.2.3 Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2018-2029)
    4.3 Global Inhalable Drug Delivery Devices Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Inhalable Drug Delivery Devices Sales by Application (2018-2029)
        5.1.1 Global Inhalable Drug Delivery Devices Sales by Application (2018-2023)
        5.1.2 Global Inhalable Drug Delivery Devices Sales by Application (2024-2029)
        5.1.3 Global Inhalable Drug Delivery Devices Sales Market Share by Application (2018-2029)
    5.2 Global Inhalable Drug Delivery Devices Revenue by Application (2018-2029)
        5.2.1 Global Inhalable Drug Delivery Devices Revenue by Application (2018-2023)
        5.2.2 Global Inhalable Drug Delivery Devices Revenue by Application (2024-2029)
        5.2.3 Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2018-2029)
    5.3 Global Inhalable Drug Delivery Devices Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Acorda Therapeutics Inc
        6.1.1 Acorda Therapeutics Inc Corporation Information
        6.1.2 Acorda Therapeutics Inc Description and Business Overview
        6.1.3 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
        6.1.5 Acorda Therapeutics Inc Recent Developments/Updates
    6.2 Baxter International Inc
        6.2.1 Baxter International Inc Corporation Information
        6.2.2 Baxter International Inc Description and Business Overview
        6.2.3 Baxter International Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Baxter International Inc Inhalable Drug Delivery Devices Product Portfolio
        6.2.5 Baxter International Inc Recent Developments/Updates
    6.3 Bellerophon Therapeutics Inc
        6.3.1 Bellerophon Therapeutics Inc Corporation Information
        6.3.2 Bellerophon Therapeutics Inc Description and Business Overview
        6.3.3 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
        6.3.5 Bellerophon Therapeutics Inc Recent Developments/Updates
    6.4 Zambon
        6.4.1 Zambon Corporation Information
        6.4.2 Zambon Description and Business Overview
        6.4.3 Zambon Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Zambon Inhalable Drug Delivery Devices Product Portfolio
        6.4.5 Zambon Recent Developments/Updates
    6.5 Canigma A.L LTD
        6.5.1 Canigma A.L LTD Corporation Information
        6.5.2 Canigma A.L LTD Description and Business Overview
        6.5.3 Canigma A.L LTD Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Canigma A.L LTD Inhalable Drug Delivery Devices Product Portfolio
        6.5.5 Canigma A.L LTD Recent Developments/Updates
    6.6 Edixomed Ltd
        6.6.1 Edixomed Ltd Corporation Information
        6.6.2 Edixomed Ltd Description and Business Overview
        6.6.3 Edixomed Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Edixomed Ltd Inhalable Drug Delivery Devices Product Portfolio
        6.6.5 Edixomed Ltd Recent Developments/Updates
    6.7 IDTx Systems, Inc.
        6.6.1 IDTx Systems, Inc. Corporation Information
        6.6.2 IDTx Systems, Inc. Description and Business Overview
        6.6.3 IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Portfolio
        6.7.5 IDTx Systems, Inc. Recent Developments/Updates
    6.8 Impel NeuroPharma Inc
        6.8.1 Impel NeuroPharma Inc Corporation Information
        6.8.2 Impel NeuroPharma Inc Description and Business Overview
        6.8.3 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Portfolio
        6.8.5 Impel NeuroPharma Inc Recent Developments/Updates
    6.9 Kanabo Research Ltd
        6.9.1 Kanabo Research Ltd Corporation Information
        6.9.2 Kanabo Research Ltd Description and Business Overview
        6.9.3 Kanabo Research Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Kanabo Research Ltd Inhalable Drug Delivery Devices Product Portfolio
        6.9.5 Kanabo Research Ltd Recent Developments/Updates
    6.10 Mallinckrodt Plc
        6.10.1 Mallinckrodt Plc Corporation Information
        6.10.2 Mallinckrodt Plc Description and Business Overview
        6.10.3 Mallinckrodt Plc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Mallinckrodt Plc Inhalable Drug Delivery Devices Product Portfolio
        6.10.5 Mallinckrodt Plc Recent Developments/Updates
    6.11 Medical Developments International Ltd
        6.11.1 Medical Developments International Ltd Corporation Information
        6.11.2 Medical Developments International Ltd Inhalable Drug Delivery Devices Description and Business Overview
        6.11.3 Medical Developments International Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Medical Developments International Ltd Inhalable Drug Delivery Devices Product Portfolio
        6.11.5 Medical Developments International Ltd Recent Developments/Updates
    6.12 Medspray BV
        6.12.1 Medspray BV Corporation Information
        6.12.2 Medspray BV Inhalable Drug Delivery Devices Description and Business Overview
        6.12.3 Medspray BV Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Medspray BV Inhalable Drug Delivery Devices Product Portfolio
        6.12.5 Medspray BV Recent Developments/Updates
    6.13 NeuroproteXeon Inc
        6.13.1 NeuroproteXeon Inc Corporation Information
        6.13.2 NeuroproteXeon Inc Inhalable Drug Delivery Devices Description and Business Overview
        6.13.3 NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Portfolio
        6.13.5 NeuroproteXeon Inc Recent Developments/Updates
    6.14 Next Safety, Inc.
        6.14.1 Next Safety, Inc. Corporation Information
        6.14.2 Next Safety, Inc. Inhalable Drug Delivery Devices Description and Business Overview
        6.14.3 Next Safety, Inc. Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.14.4 Next Safety, Inc. Inhalable Drug Delivery Devices Product Portfolio
        6.14.5 Next Safety, Inc. Recent Developments/Updates
    6.15 Nobilis Therapeutics Inc
        6.15.1 Nobilis Therapeutics Inc Corporation Information
        6.15.2 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Description and Business Overview
        6.15.3 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.15.4 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
        6.15.5 Nobilis Therapeutics Inc Recent Developments/Updates
    6.16 Sandoz International GmbH
        6.16.1 Sandoz International GmbH Corporation Information
        6.16.2 Sandoz International GmbH Inhalable Drug Delivery Devices Description and Business Overview
        6.16.3 Sandoz International GmbH Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.16.4 Sandoz International GmbH Inhalable Drug Delivery Devices Product Portfolio
        6.16.5 Sandoz International GmbH Recent Developments/Updates
    6.17 Vero biotech
        6.17.1 Vero biotech Corporation Information
        6.17.2 Vero biotech Inhalable Drug Delivery Devices Description and Business Overview
        6.17.3 Vero biotech Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
        6.17.4 Vero biotech Inhalable Drug Delivery Devices Product Portfolio
        6.17.5 Vero biotech Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Inhalable Drug Delivery Devices Industry Chain Analysis
    7.2 Inhalable Drug Delivery Devices Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Inhalable Drug Delivery Devices Production Mode & Process
    7.4 Inhalable Drug Delivery Devices Sales and Marketing
        7.4.1 Inhalable Drug Delivery Devices Sales Channels
        7.4.2 Inhalable Drug Delivery Devices Distributors
    7.5 Inhalable Drug Delivery Devices Customers

 8 Inhalable Drug Delivery Devices Market Dynamics
    8.1 Inhalable Drug Delivery Devices Industry Trends
    8.2 Inhalable Drug Delivery Devices Market Drivers
    8.3 Inhalable Drug Delivery Devices Market Challenges
    8.4 Inhalable Drug Delivery Devices Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock